ArticlePloS one2025
Mapping the temporal transcriptomic signature of a viral pathogen through CAGE and nanopore sequencing.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multi-platform profiling reveals host- and cell -type-specific pseudorabies virus gene expression.Scientific reports · 2026Article
- Cross-Species Analysis of Transcriptomic Response to Alpha-Herpesvirus Infection in Human, Bovine and Equine Cells.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionEquid alphaherpesvirus 1 (EHV-1), a veterinary pathogen belonging to the Varicellovirus genus, is responsible for significant economic losses in the global equine sector. This research involved timescale gene expression profiling and transcriptional reannotation of this herpesvirus.
methodsWe employed CAGE sequencing on the Illumina platform to determine transcript start sites, alongside long-read direct cDNA sequencing on Oxford Nanopore Technology platform to detect full-length viral transcripts. Samples were collected in triplicate at nine distinct stages of the viral lifecycle. We also applied protein synthesis inhibition to determine the immediate-early gene expression of the virus. Earlier data on native RNA sequencing was also utilized to validate the results. The sequencing data were processed using the LoRTIA and NAGATA software tools.
resultsThe time-course analysis of viral transcript expression using long-read dcDNA-Seq enabled the characterization of these transcripts based on their kinetic behavior throughout the replication cycle. Furthermore, the study involved a comprehensive reannotation of the EHV-1 transcriptome. CAGE analysis helped identify the transcription start sites and promoter regions, while direct cDNA sequencing provided a more accurate approach to capturing full-length transcripts and isoform diversity. Through an integrated approach, we identified and validated numerous novel transcripts, thereby refining the EHV-1 transcriptome annotation. These methods allowed for a more detailed and accurate mapping of the EHV-1 transcriptome, uncovering previously unknown transcripts and refining the existing annotations.
conclusionsThe shifting patterns in transcript isoforms and overlaps suggest a sophisticated regulatory network that enables EHV-1 to precisely modulate gene expression throughout its replication cycle. The presence of multiple isoforms per gene indicates that the virus can adapt to different stages of infection by producing a variety of transcripts. This likely enhances its genomic efficiency and allows it to respond more effectively to the host's environment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.